🇯🇵 Portrazza in Japan

PMDA authorised Portrazza on 18 June 2019

Marketing authorisation

PMDA — authorised 18 June 2019

  • Marketing authorisation holder: ELI LILLY JAPAN K.K.
  • Status: approved

Portrazza in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Japan

Frequently asked questions

Is Portrazza approved in Japan?

Yes. PMDA authorised it on 18 June 2019.

Who is the marketing authorisation holder for Portrazza in Japan?

ELI LILLY JAPAN K.K. holds the Japanese marketing authorisation.